Benitec Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $-833 | $0 | $0 | $0 |
Gross Profit | -124 | -119 | -120 | -118 |
EBITDA | -14,306 | -13,463 | -13,257 | -9,685 |
EBIT | -14,430 | -13,582 | -13,377 | -9,803 |
Net Income | -12,809 | -11,935 | -11,837 | -8,965 |
Net Change In Cash | -833 | 0 | 0 | 0 |
Free Cash Flow | -5,018 | -4,927 | -3,787 | -3,351 |
Cash | 179,972 | 184,761 | 188,790 | 94,479 |
Basic Shares | 46,558 | 49,386 | 45,970 | 41,521 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $216 | $75 |
Gross Profit | -481 | -396 | -343 | 75 |
EBITDA | -50,711 | -41,369 | -22,147 | -18,700 |
EBIT | -51,192 | -41,765 | -22,490 | -19,081 |
Net Income | -45,546 | -37,917 | -21,751 | -19,562 |
Net Change In Cash | 0 | 0 | 216 | 75 |
Free Cash Flow | -16,623 | -23,606 | -19,582 | -18,013 |
Cash | 179,972 | 97,744 | 50,866 | 2,477 |
Basic Shares | 46,558 | 36,209 | 10,275 | 1,385 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.26 |
2026-03-31 | -$0.24 |
2025-12-31 | -$0.26 |
2025-09-30 | -$0.22 |